TRELAGLIPT 50 is an advanced anti-diabetic medication containing Trelagliptin 50 mg, specially developed to support effective and long-lasting blood sugar management in individuals with Type 2 Diabetes Mellitus. Available in tablet form, TRELAGLIPT 50 works through DPP-4 inhibition, helping improve the body’s natural glucose regulation and supporting healthier glycemic control.

Designed as a once-weekly therapy, TRELAGLIPT 50 offers a convenient treatment approach that may help improve patient adherence while maintaining sustained blood sugar control with a low risk of hypoglycemia when used as prescribed.